Boston Financial Management’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $1.72M | Sell |
18,879
-10
| -0.1% | -$954 | 0.05% | 156 |
|
|
2024
Q3 | $1.96M | Sell |
18,889
-1,930
| -9% | -$197K | 0.06% | 150 |
|
|
2024
Q2 | $2.02M | Sell |
20,819
-1,068
| -5% | -$98.5K | 0.06% | 142 |
|
|
2024
Q1 | $1.97M | Sell |
21,887
-95
| -0.4% | -$8.05K | 0.06% | 145 |
|
|
2023
Q4 | $1.75M | Sell |
21,982
-4,406
| -17% | -$331K | 0.06% | 146 |
|
|
2023
Q3 | $1.88M | Sell |
26,388
-1,479
| -5% | -$111K | 0.07% | 138 |
|
|
2023
Q2 | $2.15M | Sell |
27,867
-3,235
| -10% | -$250K | 0.08% | 134 |
|
|
2023
Q1 | $2.34M | Sell |
31,102
-2,479
| -7% | -$184K | 0.09% | 129 |
|
|
2022
Q4 | $2.65M | Buy |
33,581
+454
| +1% | +$34K | 0.11% | 121 |
|
|
2022
Q3 | $2.33M | Buy |
33,127
+12,967
| +64% | +$1.02M | 0.1% | 116 |
|
|
2022
Q2 | $1.62M | Sell |
20,160
-610
| -3% | -$47.7K | 0.07% | 129 |
|
|
2022
Q1 | $1.57M | Sell |
20,770
-2,426
| -10% | -$192K | 0.06% | 141 |
|
|
2021
Q4 | $1.98M | Buy |
23,196
+1,241
| +6% | +$96.9K | 0.07% | 113 |
|
|
2021
Q3 | $1.66M | Buy |
21,955
+2,573
| +13% | +$204K | 0.07% | 115 |
|
|
2021
Q2 | $1.58M | Sell |
19,382
-75
| -0.4% | -$6.13K | 0.06% | 119 |
|
|
2021
Q1 | $1.53M | Sell |
19,457
-2,796
| -13% | -$219K | 0.07% | 116 |
|
|
2020
Q4 | $1.9M | Sell |
22,253
-553
| -2% | -$45.7K | 0.09% | 100 |
|
|
2020
Q3 | $1.76M | Buy |
22,806
+20
| +0.1% | +$1.52K | 0.09% | 103 |
|
|
2020
Q2 | $1.67M | Buy |
22,786
+46
| +0.2% | +$3.27K | 0.09% | 100 |
|
|
2020
Q1 | $1.51M | Sell |
22,740
-405
| -2% | -$28.6K | 0.1% | 103 |
|
|
2019
Q4 | $1.59M | Sell |
23,145
-1,700
| -7% | -$116K | 0.09% | 114 |
|
|
2019
Q3 | $1.83M | Buy |
24,845
+3,842
| +18% | +$279K | 0.1% | 114 |
|
|
2019
Q2 | $1.5M | Buy |
21,003
+58
| +0.3% | +$4.12K | 0.09% | 121 |
|
|
2019
Q1 | $1.44M | Sell |
20,945
-3,000
| -13% | -$194K | 0.09% | 122 |
|
|
2018
Q4 | $1.43M | Sell |
23,945
-805
| -3% | -$50.4K | 0.1% | 121 |
|
|
2018
Q3 | $1.66M | Sell |
24,750
-2,650
| -10% | -$177K | 0.1% | 135 |
|
|
2018
Q2 | $1.78M | Sell |
27,400
-4,788
| -15% | -$313K | 0.12% | 128 |
|
|
2018
Q1 | $2.31M | Sell |
32,188
-27,963
| -46% | -$2.01M | 0.16% | 125 |
|
|
2017
Q4 | $4.54M | Sell |
60,151
-715
| -1% | -$52.2K | 0.3% | 99 |
|
|
2017
Q3 | $4.43M | Sell |
60,866
-516
| -0.8% | -$37.2K | 0.32% | 103 |
|
|
2017
Q2 | $4.55M | Sell |
61,382
-4,575
| -7% | -$340K | 0.33% | 104 |
|
|
2017
Q1 | $4.83M | Sell |
65,957
-5,406
| -8% | -$378K | 0.36% | 97 |
|
|
2016
Q4 | $4.67M | Sell |
71,363
-197
| -0.3% | -$13.5K | 0.37% | 93 |
|
|
2016
Q3 | $5.3M | Sell |
71,560
-2,337
| -3% | -$173K | 0.43% | 91 |
|
|
2016
Q2 | $5.41M | Buy |
73,897
+734
| +1% | +$52.3K | 0.44% | 91 |
|
|
2016
Q1 | $5.17M | Sell |
73,163
-403
| -0.5% | -$26.8K | 0.78% | 47 |
|
|
2015
Q4 | $4.9M | Buy |
73,566
+890
| +1% | +$59.2K | 0.7% | 52 |
|
|
2015
Q3 | $4.61M | Sell |
72,676
-2,580
| -3% | -$169K | 0.65% | 53 |
|
|
2015
Q2 | $4.92M | Sell |
75,256
-3,569
| -5% | -$242K | 0.63% | 52 |
|
|
2015
Q1 | $5.47M | Sell |
78,825
-2,593
| -3% | -$179K | 0.68% | 47 |
|
|
2014
Q4 | $5.63M | Buy |
81,418
+1,535
| +2% | +$104K | 0.71% | 46 |
|
|
2014
Q3 | $5.21M | Sell |
79,883
-11,055
| -12% | -$729K | 0.68% | 49 |
|
|
2014
Q2 | $6.2M | Buy |
90,938
+10,280
| +13% | +$689K | 0.82% | 40 |
|
|
2014
Q1 | $5.23M | Buy |
80,658
+3,749
| +5% | +$236K | 0.7% | 46 |
|
|
2013
Q4 | $5.01M | Buy |
76,909
+2,765
| +4% | +$177K | 0.69% | 46 |
|
|
2013
Q3 | $4.4M | Buy |
74,144
+14,675
| +25% | +$869K | 0.66% | 48 |
|
|
2013
Q2 | $3.41M | Buy |
+59,469
| New | +$3.53M | 0.53% | 59 |
|
Other funds holding CL
Boston Financial Management's CL Position: Q4 2024 in Review
Boston Financial Management reduced its Colgate-Palmolive (CL) stake by 0.05% in Q4 2024, selling an estimated $954 and leaving 18,879 shares worth $1.72M. The position accounts for 0.05% of the portfolio, ranked #156.
Boston Financial Management first reported a position in CL in Q2 2013 and has held it in 47 quarters since. The position peaked at $6.2M in Q2 2014. 1,933 funds tracked by Wall St. Rank hold CL as of Q4 2024.
- Boston Financial Management held 18,879 shares of Colgate-Palmolive worth $1.72M as of Q4 2024.
- Boston Financial Management sold 10 Colgate-Palmolive shares in Q4 2024, an estimated $954.
- Colgate-Palmolive made up 0.05% of Boston Financial Management's portfolio in Q4 2024, its #156 holding.
- Boston Financial Management first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 47 quarters since.
- Boston Financial Management's Colgate-Palmolive position peaked at $6.2M in Q2 2014.
- 1,933 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2024.
Based on Boston Financial Management's 13F filing for Q4 2024, filed 3 Feb 2025.